Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.

201363 citationsJournal Article

Authors

Clóvis Orlando da Fonseca · Universidade Federal Fluminense

Raphael M. Teixeira

Júlio Cesar T Silva

Juliana de Saldanha da Gama Fischer

Osório C Meirelles

José Alberto Landeiro

Thereza Quírico‐Santos

Abstract

After 4 years under exclusive POH treatment, 19% of patients still remain in clinical remission. Long-term POH inhalation chemotherapy is a safe and non-invasive strategy efficient for recurrent malignant glioma.

Topics & Keywords

Glioma Diagnosis and Treatment Nanoplatforms for cancer theranostics Brain Metastases and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 33, Issue 12, pp. 5625-31

Field-Weighted Citation Impact: 2.02